Embecta Corp (EMBC)
14.12
-0.08
(-0.56%)
USD |
NASDAQ |
May 20, 13:34
Embecta Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2022 | 3.771 |
| March 29, 2022 | 4.147 |
| March 28, 2022 | 4.504 |
| March 25, 2022 | 4.453 |
| Date | Value |
|---|---|
| March 24, 2022 | 4.599 |
| March 23, 2022 | 4.349 |
| March 22, 2022 | 4.866 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.771
Minimum
Mar 30 2022
4.866
Maximum
Mar 22 2022
4.384
Average
4.453
Median
Mar 25 2022
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.117 |
| Perspective Therapeutics Inc | 4.442 |
| Protalix BioTherapeutics Inc | 2.880 |
| Electromed Inc | 3.471 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 11.67 |
| PS Ratio | 0.7198 |
| Price to Free Cash Flow | 86.71 |
| Price | 14.12 |
| Earnings Yield | 8.57% |
| Market Cap | 814.30M |
| Operating PE Ratio | 4.961 |
| Normalized PE Ratio | 11.67 |